HD
43
8
COF
48
3
CVX
25
14
WHR
61
3
MDT
59
4
IBM
53
2
PCG
59
9
EQR
33
6
THC
52
9
CINF
24
-8
APA
30
5
LEN
21
3
T
32
2
PBI
30
-8
KMI
69
8
DD
44
2
WBA
41
3
CF
47
5
WM
53
2
IP
53
3
HD
43
8
COF
48
3
CVX
25
14
WHR
61
3
MDT
59
4
IBM
53
2
PCG
59
9
EQR
33
6
THC
52
9
CINF
24
-8
APA
30
5
LEN
21
3
T
32
2
PBI
30
-8
KMI
69
8
DD
44
2
WBA
41
3
CF
47
5
WM
53
2
IP
53
3
Financhill
Back

Akero Therapeutics 10K Form

Sell
32

AKRO
Akero Therapeutics

Last Price:
$28.40
Seasonality Move:
-9.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AKRO News And Ratings

See the #1 stock for the next 7 days that we like better than AKRO

AKRO Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-70.4M
Price / Cash Flow: 0
Annual Sales: $10.61
Price / Book: 2.77

Profitability

EPS (TTM): -3.78000
Net Income (TTM): $-237.2M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Akero Therapeutics Earnings Forecast

Key Akero Therapeutics Financial Ratios

  • The Interest Expense is -2.04% of Operating Income.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Akero Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AKRO
CUSIP: 00973Y
Website: akerotx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AKRO Technical Analysis vs Fundamental Analysis

Sell
32
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy or a Sell?